1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Chlamydia
1.2.3 Syphilis
1.2.4 Gonorrhea
1.2.5 Herpes Simplex Virus
1.2.6 Human Papilloma Virus
1.2.7 Human Immunodeficiency Virus
1.2.8 Others
1.3 Market by Application
1.3.1 Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Laboratory Testing
1.3.3 Point of Care (POC) Testing
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Sexually Transmitted Diseases (STD) Testing Market Perspective (2017-2028)
2.2 Sexually Transmitted Diseases (STD) Testing Growth Trends by Region
2.2.1 Sexually Transmitted Diseases (STD) Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Sexually Transmitted Diseases (STD) Testing Historic Market Size by Region (2017-2022)
2.2.3 Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Region (2023-2028)
2.3 Sexually Transmitted Diseases (STD) Testing Market Dynamics
2.3.1 Sexually Transmitted Diseases (STD) Testing Industry Trends
2.3.2 Sexually Transmitted Diseases (STD) Testing Market Drivers
2.3.3 Sexually Transmitted Diseases (STD) Testing Market Challenges
2.3.4 Sexually Transmitted Diseases (STD) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sexually Transmitted Diseases (STD) Testing Players by Revenue
3.1.1 Global Top Sexually Transmitted Diseases (STD) Testing Players by Revenue (2017-2022)
3.1.2 Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Players (2017-2022)
3.2 Global Sexually Transmitted Diseases (STD) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sexually Transmitted Diseases (STD) Testing Revenue
3.4 Global Sexually Transmitted Diseases (STD) Testing Market Concentration Ratio
3.4.1 Global Sexually Transmitted Diseases (STD) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Diseases (STD) Testing Revenue in 2021
3.5 Sexually Transmitted Diseases (STD) Testing Key Players Head office and Area Served
3.6 Key Players Sexually Transmitted Diseases (STD) Testing Product Solution and Service
3.7 Date of Enter into Sexually Transmitted Diseases (STD) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sexually Transmitted Diseases (STD) Testing Breakdown Data by Type
4.1 Global Sexually Transmitted Diseases (STD) Testing Historic Market Size by Type (2017-2022)
4.2 Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Type (2023-2028)
5 Sexually Transmitted Diseases (STD) Testing Breakdown Data by Application
5.1 Global Sexually Transmitted Diseases (STD) Testing Historic Market Size by Application (2017-2022)
5.2 Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Sexually Transmitted Diseases (STD) Testing Market Size (2017-2028)
6.2 North America Sexually Transmitted Diseases (STD) Testing Market Size by Type
6.2.1 North America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2017-2022)
6.2.2 North America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2023-2028)
6.2.3 North America Sexually Transmitted Diseases (STD) Testing Market Share by Type (2017-2028)
6.3 North America Sexually Transmitted Diseases (STD) Testing Market Size by Application
6.3.1 North America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2017-2022)
6.3.2 North America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2023-2028)
6.3.3 North America Sexually Transmitted Diseases (STD) Testing Market Share by Application (2017-2028)
6.4 North America Sexually Transmitted Diseases (STD) Testing Market Size by Country
6.4.1 North America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2017-2022)
6.4.2 North America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Sexually Transmitted Diseases (STD) Testing Market Size (2017-2028)
7.2 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Type
7.2.1 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Type (2017-2022)
7.2.2 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Type (2023-2028)
7.2.3 Europe Sexually Transmitted Diseases (STD) Testing Market Share by Type (2017-2028)
7.3 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Application
7.3.1 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Application (2017-2022)
7.3.2 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Application (2023-2028)
7.3.3 Europe Sexually Transmitted Diseases (STD) Testing Market Share by Application (2017-2028)
7.4 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country
7.4.1 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country (2017-2022)
7.4.2 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size (2017-2028)
8.2 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Type
8.2.1 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Application
8.3.1 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Region
8.4.1 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Sexually Transmitted Diseases (STD) Testing Market Size (2017-2028)
9.2 Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Type
9.2.1 Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2017-2022)
9.2.2 Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2023-2028)
9.2.3 Latin America Sexually Transmitted Diseases (STD) Testing Market Share by Type (2017-2028)
9.3 Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Application
9.3.1 Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2017-2022)
9.3.2 Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2023-2028)
9.3.3 Latin America Sexually Transmitted Diseases (STD) Testing Market Share by Application (2017-2028)
9.4 Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country
9.4.1 Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2017-2022)
9.4.2 Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size (2017-2028)
10.2 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Type
10.2.1 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Application
10.3.1 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Country
10.4.1 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 ROCHE HOLDINGS
11.1.1 ROCHE HOLDINGS Company Details
11.1.2 ROCHE HOLDINGS Business Overview
11.1.3 ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Introduction
11.1.4 ROCHE HOLDINGS Revenue in Sexually Transmitted Diseases (STD) Testing Business (2017-2022)
11.1.5 ROCHE HOLDINGS Recent Developments
11.2 BIOMERIEUX
11.2.1 BIOMERIEUX Company Details
11.2.2 BIOMERIEUX Business Overview
11.2.3 BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Introduction
11.2.4 BIOMERIEUX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2017-2022)
11.2.5 BIOMERIEUX Recent Developments
11.3 HOLOGIC
11.3.1 HOLOGIC Company Details
11.3.2 HOLOGIC Business Overview
11.3.3 HOLOGIC Sexually Transmitted Diseases (STD) Testing Introduction
11.3.4 HOLOGIC Revenue in Sexually Transmitted Diseases (STD) Testing Business (2017-2022)
11.3.5 HOLOGIC Recent Developments
11.4 BECTON DICKINSON
11.4.1 BECTON DICKINSON Company Details
11.4.2 BECTON DICKINSON Business Overview
11.4.3 BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Introduction
11.4.4 BECTON DICKINSON Revenue in Sexually Transmitted Diseases (STD) Testing Business (2017-2022)
11.4.5 BECTON DICKINSON Recent Developments
11.5 ORASURE
11.5.1 ORASURE Company Details
11.5.2 ORASURE Business Overview
11.5.3 ORASURE Sexually Transmitted Diseases (STD) Testing Introduction
11.5.4 ORASURE Revenue in Sexually Transmitted Diseases (STD) Testing Business (2017-2022)
11.5.5 ORASURE Recent Developments
11.6 DANAHER
11.6.1 DANAHER Company Details
11.6.2 DANAHER Business Overview
11.6.3 DANAHER Sexually Transmitted Diseases (STD) Testing Introduction
11.6.4 DANAHER Revenue in Sexually Transmitted Diseases (STD) Testing Business (2017-2022)
11.6.5 DANAHER Recent Developments
11.7 AFFYMETRIX
11.7.1 AFFYMETRIX Company Details
11.7.2 AFFYMETRIX Business Overview
11.7.3 AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Introduction
11.7.4 AFFYMETRIX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2017-2022)
11.7.5 AFFYMETRIX Recent Developments
11.8 ABBOTT LABORATORIES
11.8.1 ABBOTT LABORATORIES Company Details
11.8.2 ABBOTT LABORATORIES Business Overview
11.8.3 ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Introduction
11.8.4 ABBOTT LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2017-2022)
11.8.5 ABBOTT LABORATORIES Recent Developments
11.9 BIO-RAD LABORATORIES
11.9.1 BIO-RAD LABORATORIES Company Details
11.9.2 BIO-RAD LABORATORIES Business Overview
11.9.3 BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Introduction
11.9.4 BIO-RAD LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2017-2022)
11.9.5 BIO-RAD LABORATORIES Recent Developments
11.10 DIASORIN
11.10.1 DIASORIN Company Details
11.10.2 DIASORIN Business Overview
11.10.3 DIASORIN Sexually Transmitted Diseases (STD) Testing Introduction
11.10.4 DIASORIN Revenue in Sexually Transmitted Diseases (STD) Testing Business (2017-2022)
11.10.5 DIASORIN Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Chlamydia
Table 3. Key Players of Syphilis
Table 4. Key Players of Gonorrhea
Table 5. Key Players of Herpes Simplex Virus
Table 6. Key Players of Human Papilloma Virus
Table 7. Key Players of Human Immunodeficiency Virus
Table 8. Key Players of Others
Table 9. Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 10. Global Sexually Transmitted Diseases (STD) Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Sexually Transmitted Diseases (STD) Testing Market Size by Region (2017-2022) & (US$ Million)
Table 12. Global Sexually Transmitted Diseases (STD) Testing Market Share by Region (2017-2022)
Table 13. Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 14. Global Sexually Transmitted Diseases (STD) Testing Market Share by Region (2023-2028)
Table 15. Sexually Transmitted Diseases (STD) Testing Market Trends
Table 16. Sexually Transmitted Diseases (STD) Testing Market Drivers
Table 17. Sexually Transmitted Diseases (STD) Testing Market Challenges
Table 18. Sexually Transmitted Diseases (STD) Testing Market Restraints
Table 19. Global Sexually Transmitted Diseases (STD) Testing Revenue by Players (2017-2022) & (US$ Million)
Table 20. Global Sexually Transmitted Diseases (STD) Testing Revenue Share by Players (2017-2022)
Table 21. Global Top Sexually Transmitted Diseases (STD) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Diseases (STD) Testing as of 2021)
Table 22. Ranking of Global Top Sexually Transmitted Diseases (STD) Testing Companies by Revenue (US$ Million) in 2021
Table 23. Global 5 Largest Players Market Share by Sexually Transmitted Diseases (STD) Testing Revenue (CR5 and HHI) & (2017-2022)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Sexually Transmitted Diseases (STD) Testing Product Solution and Service
Table 26. Date of Enter into Sexually Transmitted Diseases (STD) Testing Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Sexually Transmitted Diseases (STD) Testing Market Size by Type (2017-2022) & (US$ Million)
Table 29. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Type (2017-2022)
Table 30. Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 31. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Type (2023-2028)
Table 32. Global Sexually Transmitted Diseases (STD) Testing Market Size by Application (2017-2022) & (US$ Million)
Table 33. Global Sexually Transmitted Diseases (STD) Testing Revenue Share by Application (2017-2022)
Table 34. Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 35. Global Sexually Transmitted Diseases (STD) Testing Revenue Share by Application (2023-2028)
Table 36. North America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2017-2022) & (US$ Million)
Table 37. North America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2023-2028) & (US$ Million)
Table 38. North America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2017-2022) & (US$ Million)
Table 39. North America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2023-2028) & (US$ Million)
Table 40. North America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2017-2022) & (US$ Million)
Table 41. North America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2023-2028) & (US$ Million)
Table 42. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Type (2017-2022) & (US$ Million)
Table 43. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Type (2023-2028) & (US$ Million)
Table 44. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Application (2017-2022) & (US$ Million)
Table 45. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Application (2023-2028) & (US$ Million)
Table 46. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country (2017-2022) & (US$ Million)
Table 47. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country (2023-2028) & (US$ Million)
Table 48. Asia Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Type (2017-2022) & (US$ Million)
Table 49. Asia Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Type (2023-2028) & (US$ Million)
Table 50. Asia Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Application (2017-2022) & (US$ Million)
Table 51. Asia Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Application (2023-2028) & (US$ Million)
Table 52. Asia Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Region (2017-2022) & (US$ Million)
Table 53. Asia Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Region (2023-2028) & (US$ Million)
Table 54. Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2017-2022) & (US$ Million)
Table 55. Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2023-2028) & (US$ Million)
Table 56. Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2017-2022) & (US$ Million)
Table 57. Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2023-2028) & (US$ Million)
Table 58. Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2017-2022) & (US$ Million)
Table 59. Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Sexually Transmitted Diseases (STD) Testing Market Size by Type (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Sexually Transmitted Diseases (STD) Testing Market Size by Type (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Sexually Transmitted Diseases (STD) Testing Market Size by Application (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Sexually Transmitted Diseases (STD) Testing Market Size by Application (2023-2028) & (US$ Million)
Table 64. Middle East and Africa Sexually Transmitted Diseases (STD) Testing Market Size by Country (2017-2022) & (US$ Million)
Table 65. Middle East and Africa Sexually Transmitted Diseases (STD) Testing Market Size by Country (2023-2028) & (US$ Million)
Table 66. ROCHE HOLDINGS Company Details
Table 67. ROCHE HOLDINGS Business Overview
Table 68. ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Product
Table 69. ROCHE HOLDINGS Revenue in Sexually Transmitted Diseases (STD) Testing Business (2017-2022) & (US$ Million)
Table 70. ROCHE HOLDINGS Recent Developments
Table 71. BIOMERIEUX Company Details
Table 72. BIOMERIEUX Business Overview
Table 73. BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Product
Table 74. BIOMERIEUX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2017-2022) & (US$ Million)
Table 75. BIOMERIEUX Recent Developments
Table 76. HOLOGIC Company Details
Table 77. HOLOGIC Business Overview
Table 78. HOLOGIC Sexually Transmitted Diseases (STD) Testing Product
Table 79. HOLOGIC Revenue in Sexually Transmitted Diseases (STD) Testing Business (2017-2022) & (US$ Million)
Table 80. HOLOGIC Recent Developments
Table 81. BECTON DICKINSON Company Details
Table 82. BECTON DICKINSON Business Overview
Table 83. BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Product
Table 84. BECTON DICKINSON Revenue in Sexually Transmitted Diseases (STD) Testing Business (2017-2022) & (US$ Million)
Table 85. BECTON DICKINSON Recent Developments
Table 86. ORASURE Company Details
Table 87. ORASURE Business Overview
Table 88. ORASURE Sexually Transmitted Diseases (STD) Testing Product
Table 89. ORASURE Revenue in Sexually Transmitted Diseases (STD) Testing Business (2017-2022) & (US$ Million)
Table 90. ORASURE Recent Developments
Table 91. DANAHER Company Details
Table 92. DANAHER Business Overview
Table 93. DANAHER Sexually Transmitted Diseases (STD) Testing Product
Table 94. DANAHER Revenue in Sexually Transmitted Diseases (STD) Testing Business (2017-2022) & (US$ Million)
Table 95. DANAHER Recent Developments
Table 96. AFFYMETRIX Company Details
Table 97. AFFYMETRIX Business Overview
Table 98. AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Product
Table 99. AFFYMETRIX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2017-2022) & (US$ Million)
Table 100. AFFYMETRIX Recent Developments
Table 101. ABBOTT LABORATORIES Company Details
Table 102. ABBOTT LABORATORIES Business Overview
Table 103. ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Product
Table 104. ABBOTT LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2017-2022) & (US$ Million)
Table 105. ABBOTT LABORATORIES Recent Developments
Table 106. BIO-RAD LABORATORIES Company Details
Table 107. BIO-RAD LABORATORIES Business Overview
Table 108. BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Product
Table 109. BIO-RAD LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2017-2022) & (US$ Million)
Table 110. BIO-RAD LABORATORIES Recent Developments
Table 111. DIASORIN Company Details
Table 112. DIASORIN Business Overview
Table 113. DIASORIN Sexually Transmitted Diseases (STD) Testing Product
Table 114. DIASORIN Revenue in Sexually Transmitted Diseases (STD) Testing Business (2017-2022) & (US$ Million)
Table 115. DIASORIN Recent Developments
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sexually Transmitted Diseases (STD) Testing Market Share by Type: 2021 VS 2028
Figure 2. Chlamydia Features
Figure 3. Syphilis Features
Figure 4. Gonorrhea Features
Figure 5. Herpes Simplex Virus Features
Figure 6. Human Papilloma Virus Features
Figure 7. Human Immunodeficiency Virus Features
Figure 8. Others Features
Figure 9. Global Sexually Transmitted Diseases (STD) Testing Market Share by Application: 2021 VS 2028
Figure 10. Laboratory Testing Case Studies
Figure 11. Point of Care (POC) Testing Case Studies
Figure 12. Sexually Transmitted Diseases (STD) Testing Report Years Considered
Figure 13. Global Sexually Transmitted Diseases (STD) Testing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Sexually Transmitted Diseases (STD) Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Sexually Transmitted Diseases (STD) Testing Market Share by Region: 2021 VS 2028
Figure 16. Global Sexually Transmitted Diseases (STD) Testing Market Share by Players in 2021
Figure 17. Global Top Sexually Transmitted Diseases (STD) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Diseases (STD) Testing as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Sexually Transmitted Diseases (STD) Testing Revenue in 2021
Figure 19. North America Sexually Transmitted Diseases (STD) Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 20. North America Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Type (2017-2028)
Figure 21. North America Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Application (2017-2028)
Figure 22. North America Sexually Transmitted Diseases (STD) Testing Market Size Share by Country (2017-2028)
Figure 23. United States Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Sexually Transmitted Diseases (STD) Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 26. Europe Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Type (2017-2028)
Figure 27. Europe Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Application (2017-2028)
Figure 28. Europe Sexually Transmitted Diseases (STD) Testing Market Size Share by Country (2017-2028)
Figure 29. Germany Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. France Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. U.K. Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Italy Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Russia Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Nordic Countries Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Type (2017-2028)
Figure 37. Asia Pacific Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Application (2017-2028)
Figure 38. Asia Pacific Sexually Transmitted Diseases (STD) Testing Market Size Share by Region (2017-2028)
Figure 39. China Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Japan Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. South Korea Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. India Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Australia Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 45. Latin America Sexually Transmitted Diseases (STD) Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 46. Latin America Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Type (2017-2028)
Figure 47. Latin America Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Application (2017-2028)
Figure 48. Latin America Sexually Transmitted Diseases (STD) Testing Market Size Share by Country (2017-2028)
Figure 49. Mexico Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Brazil Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 52. Middle East and Africa Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Type (2017-2028)
Figure 53. Middle East and Africa Sexually Transmitted Diseases (STD) Testing Market Size Market Share by Application (2017-2028)
Figure 54. Middle East and Africa Sexually Transmitted Diseases (STD) Testing Market Size Share by Country (2017-2028)
Figure 55. Turkey Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. UAE Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. ROCHE HOLDINGS Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2017-2022)
Figure 59. BIOMERIEUX Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2017-2022)
Figure 60. HOLOGIC Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2017-2022)
Figure 61. BECTON DICKINSON Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2017-2022)
Figure 62. ORASURE Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2017-2022)
Figure 63. DANAHER Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2017-2022)
Figure 64. AFFYMETRIX Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2017-2022)
Figure 65. ABBOTT LABORATORIES Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2017-2022)
Figure 66. BIO-RAD LABORATORIES Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2017-2022)
Figure 67. DIASORIN Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
